(19)
(11) EP 4 816 408 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24898908.9

(22) Date of filing: 02.12.2024
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
A61K 39/395(2006.01)
C07K 16/24(2006.01)
G01N 33/68(2006.01)
A61P 37/04(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 37/04; G01N 33/68; C07K 16/2878; C07K 2317/76; C07K 2317/24; C07K 2317/71; C07K 2317/75; C07K 2317/74; C07K 2317/52; C07K 2317/35; G01N 2800/52; G01N 2333/70578
(86) International application number:
PCT/US2024/058117
(87) International publication number:
WO 2025/117965 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 01.12.2023 US 202363605306 P
17.07.2024 US 202463672340 P
28.08.2024 US 202463688121 P
28.08.2024 US 202418818268

(71) Applicant: The General Hospital Corporation
Boston, MA 02114 (US)

(72) Inventor:
  • FAUSTMAN, Denise, L.
    Boston, MA 02116 (US)

(74) Representative: Barker Brettell LLP 
100 Hagley Road Edgbaston
Birmingham, West Midlands B16 8QQ
Birmingham, West Midlands B16 8QQ (GB)

   


(54) ANTIBODIES WITH FC MODIFICATIONS AND METHODS OF USING THE SAME